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A narrative systematic review was undertaken of the literature concerning the health of people on probation or
parole (community supervision). In this paper, we provide an up-to-date summary of what is known about
substance misuse in this context. This includes estimates of the prevalence and complexity of substance misuse in
those under community supervision, and studies of the effectiveness of approaches to treating substance misuse
and engaging and retaining this population in treatment. A total of 5125 papers were identified in the initial
electronic searches, and after careful double-blind review only 31 papers related to this topic met our criteria. In
addition, a further 15 background papers were identified which are reported. We conclude that internationally
there is a high prevalence and complexity of substance misuse amongst people under community supervision.
Despite clear benefits to individuals and the wider society through improved health, and reduced re-offending; it
is still difficult to identify the most effective ways of improving health outcomes for this group in relation to
substance misuse from the research literature. Further research and investment is needed to support evidence-
based commissioning by providing a detailed and up-to-date profile of needs and the most effective ways of
addressing them, and sufficient funds to ensure that appropriate treatment is available and its impact can be
continually measured. Without this, it will be impossible to truly establish effective referral and treatment
pathways providing continuity of care for individuals as they progress through, and exit, the criminal justice
pathway.1. Background
‘Substance misuse’ includes improper use of alcohol and/or legal or
illegal drugs, and addiction, as opposed to drinking in moderation, or
using medication as prescribed. Thus it includes but is not restricted to,
diagnosable substance use disorders. Exactly which types of substance
use are considered to be illegal, and the consequences of this, has varied
over time, and also varies by location (Loue, 2003). Often substance
misuse is comorbid with other health issues such as mental illness, and
may also be combined with experiencing negative social determinants of
health such as unemployment and homelessness. Such complexity of
need can form a barrier to healthcare access, with, for example, mental
health services being unwilling to accept people with ongoing substance
misuse problems. Substance misuse can also be a driver of offending
behaviour, and consequently, is something that criminal justice as well as
health services have a role in monitoring and addressing. For peopleifield).
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er B.V. This is an open access article uunder community supervision, it is important that effective provision is
in place to support those with substance misuse needs, both to improve
their health, and to reduce associated offending behaviour.
The majority of healthcare for people on probation in England should
be commissioned by Clinical Commissioning Groups (CCGs) (NHS
Commissioning Board, 2012, 2013), with commissioning decisions being
informed by Joint Strategic Needs Assessments prepared through Health
and Wellbeing Boards (Department of Health, 2013). In addition, Local
Authorities have a non-mandated function as a condition of the public
health grant for commissioning substance misuse services. However,
many CCGs appear to be unaware of this responsibility, and people in the
criminal justice system are often not visible in these assessments (Brooker
& Ramsbotham, 2014; Brooker, Sirdifield, Ramsbotham, & Denney,
2017; Revolving Doors Agency, 2017). The profile of the health needs of
people under probation supervision differs from that of the general
population, with much research demonstrating a higher prevalence ofeptember 2020
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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eral population (Sirdifield et al., 2019). This needs to be taken into ac-
count by commissioners in order to ensure that the needs of this group
are met.
The study reported here was one part of a larger study aiming to
investigate the range and quality of healthcare for people on probation
(individuals on community sentences and post-release licences) in En-
gland, and to produce a commissioning toolkit (available at probhct.-
blogs.lincoln.ac.uk). The study included a systematic review of
international research on the most effective ways of providing healthcare
for adults on probation to achieve good health outcomes. Findings in
relation to substance misuse are reported here.
2. Methods
2.1. Search strategy
We searched MEDLINE, PsycINFO, IBSS, CINAHL, The Cochrane Li-
brary, EMBASE, AMED, ASSIA, and HMIC for papers published between
January 2000 and May 2017; and hand-searched the British Journal of
Criminology, the Probation Journal, the Irish Probation Journal, and
Health and Social Care in the Community from 2000 to September 2017.
We also hand-searched the reference lists of included papers, and the
grey literature. Further details of this and the MEDLINE search strategy
have been reported previously (Brooker, Sirdifield, & Marples, 2020;
Sirdifield, Brooker, & Marples, 2020).
2.2. Inclusion and exclusion criteria
This paper reports findings in relation to substance misuse that are
drawn from a wider review. This review had two goals. The first was to
identify what the literature tells us about the most effective approaches to
improving health outcomes for adults on probation. Our second goal was
to identify what the literature tells us about the health needs of adults on
probation, their patterns of service access, and any potential approaches
to improving health outcomes that are described in the literature, but
have not yet been subject to research or evaluation.
Consequently, two types of paper were included in the review. Firstly
studies that researched the effectiveness of an approach to improving health
outcomes for adults on probation. Papers that included people on parole
were also included, so henceforth we refer to people under community
supervision where appropriate. There were no restrictions for language
or study design.
Secondly, we included papers that met the above criteria but purely
described an approach to providing healthcare to the target population or
were illustrative of their health need as ‘background’ papers.
2.3. Assessment of relevance for inclusion in the review
Two members of the research team independently assessed titles and
abstracts and full papers where relevance was unclear. Disagreements
were resolved through discussion with a third reviewer.
As reported previously (Sirdifield, Brooker, &Marples, 2020), papers
were quality assessed using tools appropriate for the methodology used
in each study, but this assessment was not used to exclude papers from
the review.
3. Results
After duplicates were removed, 3316 papers were identified from the
database searches, of which 51were identified as appropriate for full-text
review. An additional four papers were acquired for inclusion following
the hand-searching, bringing the total to 55.
After reading these papers in full, 25 were included in the review and
20 further papers were identified and included from their reference lists.
Thus, the total number of includes was 45, of which 31 related to2
substance misuse. An additional 85 papers were classified as ‘back-
ground’, of which 15 related to substance misuse (Fig. 1).
4. Description of studies
4.1. Background papers
Four background papers provided overviews of substance misuse ser-
vices – including a Rapid Assessment and Treatment Service for Drug and
Alcohol Misusers (Murphy & Sweet, 2004), random assignment to either
a therapeutic community, a recovery home, or a usual care setting (Jason,
Olson, Harvey, 2015), a web-based intervention to increase motivation to
enter substance misuse treatment called MAPIT (Walters et al., 2014),
and a prospective model of the economic costs and benefits of intro-
ducing Alcohol Treatment Requirements in Stockport, UK (Fox, Albert-
son, Williams, Ellison, 2011).
Additionally, the background papers offered some insight into the
prevalence of substance misuse amongst those under community super-
vision, factors that increase the likelihood of substance misuse, the
benefits of treatment and advice, predictors of treatment retention, and
commentary on policy decisions around the provision of substance
misuse services.
In relation to prevalence, Murphy and Sweet (2004) and Martyn
(2012) reported the high levels of drug and alcohol misuse amongst
people on probation when compared to the general population, with
many people misusing both drugs and alcohol, and poly drug abuse
appearing to be the norm. In the latter study, staff linked drug misuse to a
current offence for 74% of those misusing drugs, and 71.3% of those
misusing alcohol.
Factors that increase the likelihood that someone will misuse drugs
and/or alcohol, or resume substance misuse after achieving abstinence
were investigated in two studies. Firstly in terms of the relationship be-
tween non-medical prescription opioid use, and victimisation, psycho-
logical distress and health status in 406 women on probation and parole
(Hall, Golder, Higgins, & Logan, 2016). Here those using non-medical
prescription opioids were “more likely to be White, have poorer gen-
eral health, and more severe psychological distress” (Hall et al., 2016, p.
113). Secondly, in relation to the rate of resumption of substance use
following release from prison, and risk factors for relapse amongst 533
adults with a history of injecting drug use in Queensland, Australia
(Winter et al., 2016). Here, the rate of resumption of use was highest in
the first month following release and was significantly associated with
being unemployed at previous interview, shorter incarceration, and use
during the index incarceration; whilst parole was a protective factor
(Winter et al., 2016, p. 104).
Predictors of treatment retention were investigated by Kelly et al.
(2011) in relation to the predictors of methadone treatment retention for
351 opioid-dependent people on programmes in Baltimore. Amongst
other factors, this study pointed to the importance of early satisfaction
with treatment as a predictor of longer-term treatment retention, and the
potential benefit of providing services to address service users’ legal
problems to avoid these impacting negatively on treatment retention.
Several papers demonstrated that providing effective treatment and/
or advice about substance misuse may play a role in preventing deaths
and in reducing harm from activities such as syringe sharing (Carter,
Ryan, & Scott, 2000; Nicosia, Kilmer, & Heaton, 2016; Small, 2007).
Finally, several papers provided commentary on policy decisions
related to the provision of substance misuse services, including the pol-
itics of addiction in Canada in relation to Vancouver's Supported Injec-
tion Facility (Small, 2007); intended and unintended consequences of
drug treatment policy (the ‘war on drugs’) in the UK (Gyngell, 2011); an
overview of the literature around methadone maintenance treatment
(Joseph, Stancliff, & Langrod, 2000); and the cost-effectiveness of the
Drug Interventions Programme (DIP) in the UK (Collins, Cuddy, &
Martin, 2016; Osborne, 2013). This was a Home Office initiative intro-
duced in England in 2003 to connect the criminal justice system and Drug
Fig. 1. PRISMA diagram
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4.2. Included studies
Overall, 31 studies on substance misuse met the criteria for inclusion
in the review. These studies were published between 2000 and 2014 in
the USA (Alemi et al., 2006; Anglin, Nosyk, Jaffe, Urada, & Evans, 2013;
Brewster, 2001; Brown, Gassman, Hetzel, & Berger, 2013; Chun et al.,
2007; Claus& Kindleberger, 2002; Cropsey et al., 2011; Evans, Li, Urada,
& Anglin, 2014; Gottfredson & Exum, 2002; Gray, 2002; Gregoire &
Burke, 2004; Gryczynski et al., 2012; Harrell, Cavanagh,& Roman, 2000;
J. F. Kelly, Finney, & Moos, 2005; S. M. Kelly, O'Grady, Jaffe, Gandhi, &
Schwartz, 2013; Kleinpeter, Deschenes, Blanks, Lepage, & Knox, 2006;3
Longshore et al., 2005; Mackin et al., 2008; Marchand, Waller, & Carey,
2006; Martin, Clapp, Alfers, & Beresford, 2004; Martin et al., 2003; Sia,
Dansereau,& Czuchry, 2000; Stageberg, Wilson,&Moore, 2001), the UK
(Ashby, Horrocks, & Kelly, 2010; Eley, Gallop, McIvor, Morgan, & Yates,
2002; Hearnden, 2000; McSweeney, Stevens, Hunt, & Turnbull, 2007;
Powell, Bankart, Christie, Bamber, & Arrindell, 2009; Turnbull &
Webster, 2007), Ireland (Hollway, Mawhinney, & Sheehy, 2007) and
Mexico (Brodie et al., 2009). Due to the heterogeneous nature of the
papers, we have organised them into subsections below.
4.2.1. Pharmacological treatments
Three studies examined outcomes of pharmacological treatments for
substance misuse, namely vigabatrin use for parolees with cocaine
C. Sirdifield et al. Forensic Science International: Mind and Law 1 (2020) 100031dependence (Brodie et al., 2009), methadone or
levo-alpha-acetylemethadol for heroin-dependent people on probation
(Gryczynski et al., 2012), and buprenorphine for opioid-dependent
women on probation or parole (Cropsey et al., 2011). These studies
illustrate the difficulties involved in trying to investigate and draw firm
conclusions about pharmacological treatments specifically in relation to
those under community supervision. There is variation across these
studies in the drugs tested, the sampling approaches used, and how
outcomes were measured. Whilst all three studies draw some cautiously
optimistic conclusions, they also demonstrate the uncertainty around
this. For example, Brodie et al. report that abstinence rates did not differ
over the whole treatment period that they studied. Rather, differences in
favour of vigabatrin were recorded in weeks 7 (p 0.02) and 9 (p 0.02)
(Brodie et al., 2009, p. 1273). All three studies show how outcomes may
also vary by personal characteristics and variables such as poly drug use,
or members of a placebo group having unauthorised access to the drug
being tested. Outcomes can also be influenced by whether or not par-
ticipants are aware of whether they are receiving a drug or a placebo
(Cropsey et al., 2011).
Overall, the lack of studies in this area, and the variation between
those that were identified means that it is impossible to draw firm con-
clusions about the most effective pharmacological treatments for use
with people under community supervision.
4.2.2. Non-pharmacological support
Two studies reported on non-pharmacological support for substance
misuse problems (Table 3).
Gray. (2002) described early outcomes from the Brooklyn Program.
Overall, 80% of those enrolled completed the treatment, and 55% of
graduates remained drug-free after completion, compared to 16% of non-
graduates.
Hollway et al. (2007) examined the impact of a residential addiction
treatment programme provided at Harristown House in Ireland on sub-
stance abuse and on participants’ attitudes towards the criminal justice
system. The health-related findings suggested that the programme had a
mixed impact on substance misuse, with 36% (n¼ 5) of cases main-
taining abstinence between completing the treatment and the end of the
data collection period, whilst 64% (n¼ 9) relapsed after completing the
treatment and 22% (n¼ 2) reported drinking regularly (Hollway et al.,
2007, pp. 116–117). Nearly two thirds of clients reported relapsing at
least once after completing the residential part of the treatment. At the
end of the data collection period, data were available for 12 participants,
11 of which reported that they were now abstinent.
4.2.3. The impact of treatment readiness and of coerced or mandatory
treatment
Numerous forms of coerced or mandatory treatment have been
introduced around the world that attempt to improve access to care for
people under community supervision, and to potentially produce cost-
savings through early intervention leading to improved health, re-
ductions in unnecessary use of crisis care, and reduced criminal justice
costs due to reductions in re-offending and improved compliance with
probation. We identified several studies relating to the impact of coercive
versus voluntary treatment on outcomes.
One could assume that those mandated to treatment would be less
ready to change and/or have worse outcomes than those attending
treatment voluntarily as the primary motivation to attend treatment may
be the avoidance of criminal charges rather than a desire to change.
However, findings from the research in this area are mixed. In a study
comparing voluntary and coerced attendance at outpatient treatment for
substance misuse in Ohio, USA, Gregoire and Burke (2004) reported that
individuals that were legally coerced to attend treatment (79% of whom
were on probation or parole) were more likely to be in the ‘action’ stage
of change than voluntary attenders, even after controlling for the severity
of current and lifetime substance abuse. Women were also more likely
than men to be in the action stage, regardless of substance abuse severity,4
or legal coercion. However, the researchers note that the study may be
subject to selection bias, as those less motivated to change may have
chosen another legal sanction such as imprisonment, rather than
attending legally coerced treatment.
Kelly et al. (2005) compared outcomes for veterans mandated to
substance use disorder treatment following criminal justice involvement,
to those for individuals with criminal justice involvement that were
accessing treatment voluntarily, and voluntary patients with no criminal
justice involvement. Some differences were reported in the characteris-
tics of the groups being compared. Findings showed that there were no
statistically significant differences between groups in satisfaction with
treatment or perceptions of the treatment environment. The mandated
group showed less of a decrease in symptoms between intake and
discharge than the other groups, but were more likely to be abstinent, in
remission, and to have encountered substance-related consequences than
the other groups at one-year follow-up (J. F. Kelly et al., 2005, p. 218).
These differences in treatment outcomes could not be explained by the
initial differences between groups. Thus, despite having less motivation
to change at intake, the mandated participants had similar perceptions of
their treatment to the other groups and “improved as much, if not more
than, other patients in their substance use outcomes” (J. F. Kelly et al.,
2005, p. 221).
Sia et al. (2000) evaluated whether attending treatment readiness
training would improve satisfaction and progress with substance misuse
treatment amongst 500 people on probation with non-violent drug-re-
lated offenses. Those with high readiness for treatment scores rated their
counsellors and sessions more highly than those with lower readiness
levels. Those with high readiness scores, and those receiving readiness
training, rated themselves as engaging with the programme more posi-
tively than others. Although not directly related to health benefits, these
positive ratings of staff, content and engagement with the programme are
all likely to have a positive impact on treatment engagement and
completion, but more research is needed to determine whether or not
readiness training is having the desired effect. A web-based Motivational
Assessment Program to Initiate Treatment is also being developed and
tested in a randomised controlled trial (see Walters et al., 2014 above).
In addition to the above, studies, we also identified literature on Drug
Treatment and Testing Orders and Alcohol Treatment Requirements in
the UK, specialist courts in the USA, and the introduction of Proposition
36 in the California Substance Abuse and Crime Prevention Act (SACPA)
as described below.
4.2.3.1. Drug treatment and Testing Orders (DTTOs). DTTOs were intro-
duced into England and Wales via the Crime and Disorder Act 1998, and
later introduced into Scotland. They could be added to an existing
community order, or stand alone, and aimed to support those whose
offending is driven by drug misuse, to reduce their drug misuse and any
associated offending behaviour. They involved partnership working be-
tween courts, probation and treatment services, including regular drugs
testing as a condition of a probation order. They have since been replaced
by Drug Rehabilitation Requirements (DRRs). We identified several pa-
pers on this topic in our review, whose aims andmethods are summarised
in Table 1.
These studies provide valuable learning in terms of the complexity of
measuring the outcomes of these orders. For example, Powell et al.
(2009) demonstrated that where sentencing occurred and where an order
commenced, impacted on the percentage of negative drug tests recorded
amongst those on a DTTO. Those sentenced in a magistrate's court and
starting their order in the community (as opposed to in custody) showed
themost improvement; whilst those showing the least improvement were
those sentenced at crown court and starting their order in the commu-
nity. Those starting their order in the community were likely to have
higher starting levels of drug use, whilst those being sentenced at crown
court were likely to be the most chaotic drug users.
Research in this area identified some of the difficulties encountered
Table 1
DTTO studies.
Reference Aim, Country and Setting Methods
Powell et al.
(2009)
Aim(s): To examine changes
in individuals' drug use
whilst on a probation based
drug treatment programme,
and to explore the
experiences of the staff
administering drug tests
Country: UK
Setting: One probation area
Sample: n¼ 331 (422 Drug
testing and treatment orders –
some were concurrent)
Mean age 26.5 years
85% male, 15% female
93% white, 6% other
Analysed urinalysis or saliva
swab drug test results for 317
people on a DTTO to compare
negative drug test results per
individual between the first and
final month of their order; and
conducted 17 semi-structured
interviews with DTTO staff over
a 3-year period. Here contem-
poraneous notes were made at
the time and data were coded
and analysed using a template
style
Turnbull and
Webster
(2007)
Aim(s): To identify the best
practice in engaging and
retaining crack users on
DTTOs
Country: UK
Setting: 3 services for crack-
using offenders in London,
West Midlands and Yorkshire
Sample:
Case files for 70 crack users:
93% male 7% female
Mean age: 31 years
2 in 5 were non-white
Interviews with key
stakeholders (n¼ 38) including
18 DTTO team members and 11
drug treatment agency staff
Interviews with crack users
(n¼ 28)
25 male, 3 female
Mean age: 32 years
20 White British, 8 other ethnic
groups
McSweeney
et al. (2007)
Aim(s): To This present “the
main findings of an
evaluation of quasi-
compulsory drug treatment
(QCT) options for drug-
dependent offenders in
England. We define QCT as
drug treatment that is
motivated, ordered or
supervised by the criminal
justice system but which
takes place outside prisons”
(p471). The focus here is on
Drug Treatment and Testing
Orders (DTTOs)
Country: UK
Setting: 10 Community
based drug treatment sites in
London and Kent
Sample: A random sample of
157 “people who entered
community-based drug
treatment at one of ten research
sites across London and Kent
between June 2003 and January
2004” (p473). 89 were on a
DTTO, and 68 were voluntary
clients at the same treatment site
120 male, 37 female
Average age: 31 years
125 White
The voluntary group were more
likely to report “having been
prescribed medication for
psychological or emotional
problems (n¼ 39; 57 per cent)
than the DTTO group (n¼ 28; 32
per cent) (c2¼ 10.56, d.f.¼ 1,
p< 0.01). They were also more
likely to have experienced
serious thoughts of suicide
(c2¼ 7.89, d.f.¼ 1, p< 0.05); to
have actually attempted suicide
(c2¼ 5.14, d.f.¼ 1, p< 0.05);
and have more lifetime suicide
attempts than the QCT group
(t¼2.20, d.f.¼ 155,
p< 0.05)” (p474). No
differences between groups in
terms of previous exposure to
treatment
Participants were asked a set of
questions that included adapted
versions of the European
Addiction Severity Index,
Table 1 (continued )
Reference Aim, Country and Setting Methods
questions around perception of
pressure, the Readiness to
Change Questionnaire
“At intake (t1), questions about
recent behaviour and
circumstances referred to the
thirty days prior to arrest for
those in QCT and the thirty days
prior to treatment admission for
the ‘volunteers’. These questions
were administered again at six
(t2), twelve (t3) and 18-month
(t4) follow-up intervals” (p473)
In-depth interviews with a pur-
posive sample of health and
criminal justice professionals
(n¼ 38)
Eley et al.
(2002)
Aim(s): “to evaluate the
effectiveness of the pilot
DTTOs in reducing drug
misuse and associated
offending and to assess the
costs of DTTOs and
alternative disposals” (pi)
Country: UK
Setting: Schemes in Glasgow
and Fife
Sample: Data were collected
from numerous sources
including: social enquiry reports
and DTTO assessments (n¼ 59),
questionnaires completed by
DTTO staff (n¼ 47 at baseline
and n¼ 33 at six month follow
up) and treatment providers
(n¼ 45 from baseline and
n¼ 18 from six month follow
up), interviews with key
stakeholders including people
on DTTOs (n¼ 30 staff, and 38
offenders), and observation of
court reviews
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with delivery of DTTOs, which may be applicable to other forms of court-
ordered treatment, particularly in terms of challenges around inter-
agency working, and availability of treatment (Eley et al., 2002;
McSweeney et al., 2007; Turnbull & Webster, 2007). It is apparent from
this research that several things are needed for these orders to be
delivered successfully (McSweeney et al., 2007; Turnbull & Webster,
2007). Firstly, clear communication and agreement about who is suitable
for an order and whether or not they have attended a treatment service.
Secondly, clarity in probation National Standards about what a realistic
and acceptable level of drug use whilst on a DTTO is, how quickly par-
ticipants can become drug-free, the likelihood of relapse, and how the
results of drug screenings (positive or negative) should be used. Thirdly,
ways of reducing delays in a) court reports showing individuals’ suit-
ability for a DTTO and b) processing breach proceedings. These are all
points to consider in implementing DRRs or other similar interventions.
Positive findings were reported in terms of the impact of these orders
on reducing drug use and offending behaviour and improving health
(Eley et al., 2002; McSweeney et al., 2007). It is noteworthy that
McSweeney et al. (2007) investigated whether after statistically con-
trolling for other factors, people receiving treatment via a DTTO would
have better retention in treatment than those attending voluntarily. This
hypothesis was not supported.
4.2.3.2. Alcohol Treatment Requirements (ATRs). Alcohol Treatment Re-
quirements were introduced in the UK under the Criminal Justice Act
2003 and are usually targeted at dependent drinkers, but in some areas,
have also been offered to those with ‘hazardous’ and ‘harmful’ patterns of
drinking (Ashby et al., 2010). In Ashby et al.'s study, data from the
probation Offender Assessment System and Case Recording Management
System, and treatment agency assessment data were examined for 81
individuals that had completed or were close to completing an ATR.
Findings showed that 70% of the sample completed the ATR within the
study period, and just 15% failed to complete it. Alcohol treatment
workers' assessments suggested that 54% had made positive changes to
their drinking behaviour and level of drinking, 11% had achieved
C. Sirdifield et al. Forensic Science International: Mind and Law 1 (2020) 100031‘controlled alcohol consumption’, and 32%were abstinent. An additional
11% had reduced their alcohol consumption. However, 16% had
continued to drink and were not engaging in treatment, 14% had dete-
riorated or relapsed whilst in treatment, and 15% of cases were described
as too complicated to classify in this manner – sometimes due to other
co-occurring conditions. For some, ATRs may provide a gateway to
accessing other services – in this study, 7% of completers were referred
for mental health treatment. However, it should be noted that engaging
in treatment does not always result in behaviour change.
4.2.3.3. Specialised courts. Specialised courts with a focus on substance
misuse exist in many settings internationally. We identified several pa-
pers relating to drug courts in our review. Reaching firm conclusions
about the effectiveness of these courts is problematic because they vary
in terms of who is eligible to participate, who can make referrals, and the
duration and content of the programmes that they offer (see Table 2).
Generally, participation is offered as an alternative to incarceration and
involves regular attendance at both court and with treatment providers
and probation, undergoing regular drug or alcohol tests, and a system of
sanctions for non-compliance or positive tests, and rewards for progress
and compliance.
Findings from these studies showed huge variation in graduation
rates across the programmes, ranging from 11.4% (Brewster, 2001) to
72% (Mackin et al., 2008). Predictors of graduation varied across studies
and included being white, having graduated high school, intravenous
drug use, not having been incarcerated in the past, having fewer positive
drug tests whilst on the programme, remaining in a programme for
longer and having fewer prior arrests.
Numerous positive outcomes from attending drug courts were re-
ported. These included being less likely to be rearrested than comparison
groups (Brewster, 2001; Gottfredson & Exum, 2002; Mackin et al., 2008;
Marchand et al., 2006); having fewer jail days (Brewster, 2001; Gott-
fredson & Exum, 2002); fewer, or a lower rate of positive drug tests
(Brewster, 2001; Mackin et al., 2008; Marchand et al., 2006), which oneTable 2
Non-pharmacological support.
Study Summary of Support Research Methods
Gray.,
(2002)
A strengths-based program for
substance abusers supervised by
the federal criminal justice sys-
tem in the Eastern district of New
York
Consists of 2-h group meetings in
a classroom for sixteen weeks,
and at least two one to one
sessions
Learning includes developing
skills around recalling and
achieving positive emotional
states, and designing and
imagining possible futures -
enabling clients to self-identify
goals and directions for change
Data were collected on 127
cases during one treatment year,
and analysis was conducted on
99 of these records, with others
being removed due to missing or
ambiguous data
Hollway
et al.
(2007)
The treatment provided is
underpinned by the Minnesota
Model 12-step philosophy and
combines motivational inter-
viewing, cognitive behavioural
therapy, and brief solution
focused theory over a period of
six weeks of residential treatment
and two years of community-
based aftercare
Treatment is accessed via
referrals from the criminal justice
system and targets those that
have come into contact with the
criminal justice system due to
drug or alcohol misuse
The researchers collected data
on 14 participants at three time
points: pre-treatment, at the end
of the residential treatment
phase, and at 3–9 months post-
admission using the Michigan
Alcohol Screening Test (MAST),
semi-structured interviews, and
the modified version of the
Criminal Sentiments Scale (CSS-
M)
6
study suggested could be further enhanced by the use of treatment and
sanctions as part of the programme rather than simply drug testing and
judicial monitoring (Harrell et al., 2000); and cost savings for the crim-
inal justice system (Mackin et al., 2008; Marchand et al., 2006). It should
be noted however, that some studies had the possibility of selection bias,
there were mixed findings regarding costs (see for example Stageberg
et al., 2001), and how outcomes were measured varied across the studies.
There are also specialised courts to support those misusing alcohol.
Martin et al. (2003) conducted a small-scale study comparing data from a
group (n¼ 19) of court ordered patients with a group of voluntary pa-
tients (n¼ 22), both of which were recruited from the outpatient disul-
firam clinic at the Department of Veterans Affairs Medical Centre in
Denver, USA (Martin et al., 2003). This study suggested that court
mandate may actually improve compliance with this type of treatment
for alcohol abuse or dependence, and may improve treatment retention
at 12 weeks, which may in turn lead to positive treatment outcomes
further down the line.
In a second study, Martin et al. (2004) examined treatment adherence
amongst 19 voluntary and 17 court-mandated patients from the original
groups in the above study at 15 months. Adherence to treatment was
measured as the percentage of prescribed visits that were attended dur-
ing the twelve months following the initial three-month observation
period used in the previous study. As well as considering the same po-
tential influencing factors as in the previous study, the researchers also
assessed resource use by counting the number of emergency visits and
hospitalisations experienced over the 12months. There was a statistically
significant difference between groups in terms of the proportion of
scheduled visits attended (p< 0.01), with those court-mandated
attending an average of 31.6% of appointments and voluntary patients
attending an average of 27.6%. A statistically significant difference
remained when the analysis was run on only those with alcohol depen-
dence (rather than abuse) diagnoses. Adherence at three months was
associated with adherence during the following twelve months.
Furthermore, greater adherence at fifteen months was significantly
associated with the number of lifetime drunk driving arrests (r¼ 0.36,
p< 0.05) and a diagnosis of alcohol abuse rather than dependence
(r¼ 0.34, p< 0.05) (Martin et al., 2004, p. 234). The remaining factors
studied did not influence adherence. There was also a non-significant
trend in the number of emergency visits, with those in the voluntary
group averaging more visits. Thus the researchers conclude that “over a
period of 15 months, court-ordered treatment may be more useful in
achieving and maintaining adherence than voluntary treatment for pa-
tients receiving supervised disulfiram” (Martin et al., 2004, p. 235).
Finally, Kleinpeter et al. (2006) described findings from a process
evaluation of a specialty court for people with both a serious mental
illness and a substance misuse problem (i.e. people with a dual diagnosis)
in Southern California. To graduate from the court “participants must be
drug- and alcohol-free for a minimum of nine months. They must be
compliant with all the conditions of probation and have completed the
treatment as directed” (Kleinpeter et al., 2006, p. 67). The concluded that
on average, specialty court participants made significant improvements
during the first six months in terms of their level of functioning and
quality of life. Most participants had been stabilised on medication. The
service was seen as successfully filling a gap for treatment and continuity
of care for those in the criminal justice system with a dual diagnosis. The
researchers recommend that future services of this nature should be
staffed by people experienced in working with individuals with mental
illness, or else specialist training should be provided. They also recom-
mend the use of individual treatment plans combining treatment for
substance misuse and mental illness, and stress the importance of
establishing partnerships with local treatment agencies to meet clients’
needs.
4.2.3.4. Proposition 36, California Substance Abuse and Crime Prevention
Act (SACPA). We identified four studies of the California Substance
Table 3
Specialist court characteristics.
Study and Setting Eligibility Who Can Refer? Summary of Programme Content Overall Graduation Rate and
Predictors of Success
Brewster., (2001)
The Chester County
Drug Court program
in Pennsylvania, USA
Participants must be charged with a
non-mandatory drug offence and
should not a) be under probation or
parole supervision when charged
with this offence or b) have a prior
record for a violent offence
Potential participants are
identified by the Chester County
Bail agency and immediately
referred to a treatment provider
for assessment and treatment
(Brewster, 2001, p. 179) whilst
the District Attorney's Office
checks that they are eligible for
the programme
Participants attend the court within a
week of referral and attend drug
testing supervised by probation
There are three stages in the
programme, each of which lasts for a
minimum of 90 days
Phase One: “at least two probation
officer (PO) contacts per week, two
drug tests per week, and Drug Court
appearance every one to three weeks”
(Brewster, 2001, p. 180)
Phase Two: “PO contacts and drug
testing are each reduced to once per
week. Drug court appearances are
required once every two to five weeks
during Phase Two” (Brewster, 2001, p.
180)
Phase Three: “PO contacts and drug
testing are reduced to once every two
weeks, and Drug Court appearances
occur every four to six weeks”
(Brewster, 2001, p. 180)
Those that complete the programme
successfully have their charges
dismissed and removed from the
record
Care is provided by the Chester County
Department of Drug and Alcohol
Services
11.4% graduated, and an
additional 3.3% were ‘closed
successful’
Survival analysis suggested that “a
greater proportion of the
comparison subjects survived over
time than did the drug court
participants” (Brewster, 2001, p.
192). However, this may be due to
more stringent termination criteria
being applied to drug court
participants
For those attending the
programme, there were no
statistically significant differences
in programme survival by gender,
ethnicity, primary drug of choice,
or frequency of drug use. However,
differences between Caucasian and
African American groups
approached statistical significance,
with Caucasians appearing to do
better. It is unclear exactly why
this was the case
Gottfredson and Exum.,
(2002)
Baltimore City Drug
Treatment Court
(BCDTC), USA
Non-violent adult offenders
supervised by the Baltimore City
Division of Parole and Probation
Paper states that these are listed
in an unpublished technical
report
Those participating in the programme
do so in lieu of a custodial sentence,
but they may also spend time in jail
whilst on the programme:
“One surprising finding was that
nearly 11 percent of the offenders
randomly assigned to drug treatment
court received incarceration-only
sentences, given that the aims of the
program are to keep offenders out of
prison and provide intensive probation
supervision” (Gottfredson & Exum,
2002, p. 348)
“After jail-based acupuncture, the
most common types of treatment
received by people attending this
specialist court were outpatient (23.7
percent) and intensive outpatient
(19.4 percent)” (Gottfredson & Exum,
2002, p. 347)
“Records as of February 2001
indicated that 31 percent of the
treatment participants and 5
percent of the control participants
had graduated from the program”
(p346)
Harrell et al. (2000)
Washington D.C.
Superior Court
All drug felony defendants -
including those committing violent
offenses and all levels of severity
and duration of drug use
Unclear Standard docket: twice-weekly drug
tests and judicial monitoring
Treatment docket: “a comprehensive
treatment program designed to
provide drug-involved individuals
with the skills, self-esteem, and
community resources necessary to
help them leave the criminal life”
(Harrell et al., 2000, p. 1)
Sanctions docket: applied penalties to
those that failed or failed to attend
drug tests and encouraged people to
access community-based treatment.
People on the non-standard
programmes had a higher chance of
receiving probation rather than a
custodial sentence if they successfully
completed the programme
“19 percent of the 140 participants
graduated from the treatment
program, and 9 percent left the
program doing well” (p6)
Mackin et al. (2008)
Harford County District
Court Adult Drug
Court program
Participants “must have an alcohol-
or drug-related or motivated
criminal charge. Most current drug
court participants are first-time
offenders with no felony charge.
However, prospective participants
Files are usually reviewed by the
State's Attorney's Office to decide
if they are eligible and sends a
letter of invitation to the potential
participant
Referrals can also be made by a
The programme had four phases and
took a minimum of 9.5 months to
complete overall. This included drug
testing, individual counselling and
group therapy combined with a range
72% graduated overall
Logistic regression showed that
“the only characteristic
significantly related to program
success was the age of first
substance use, indicating that
(continued on next page)
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Table 3 (continued )
Study and Setting Eligibility Who Can Refer? Summary of Programme Content Overall Graduation Rate and
Predictors of Success
with felonies and second-time
offenses are also eligible.
Defendants with a history of
violence, weapons charges, a
charge of possession with
indication of drug distribution, or
serious driving record violations
are generally excluded” (p2)
Public Defender, Judge and
Parole and Probation Agent
of incentives for compliance and
sanctions for non-compliance
participants were 1.16 times more
likely (p< 0.05) to graduate, or
have 16% greater chance of
graduation for each year older the
participant was a their age of first
substance use” (Mackin et al.,
2008, p. 17)
A multivariate analysis identified
that those staying in the
programme for longer being more
likely to graduate
Marchand et al. (2006)
Kalamazoo County
Adult Drug
Treatment Court
(KADTC) in
Michigan, USA
The programme was aimed at
“substance-abusing adults charged
with non-violent criminal offenses
as well as circuit court probationers
and parolees whose involvement
with Drug Court is a condition of
probation/parole” (Marchand
et al., 2006, p. 15)
Participants could be referred by a
Prosecutor or Defence Attorney,
or as a condition of probation, or
“from the Department of
Corrections if they commit a
technical violation of probation/
parole” (Marchand et al., 2006, p.
15)
The programme consisted of a
combination of drug testing and
treatment which could include
intensive outpatient therapy,
individual and group therapy sessions,
12-step programme participation,
relapse prevention groups, residential
treatment and detoxification
(Marchand et al., 2006, pp. 16–17)
27% graduated overall
Older age of first use
Alcohol as drug of choice
A lower number of prior arrests.
However, when this difference was
examined by gender, it remained
significant for men, but not for
women (Marchand et al., 2006, p.
35)
Stageberg et al. (2001)
Drug court in Polk
County, USA
Target population was people on
probation being recommended for
revocation by the Department of
Correctional Services who:
- “Had a risk score of 12 or higher
had a history of alcohol or drug
abuse
- Had substance abuse-related
technical violations or a new arrest
- Did not have a current offence
consisting of a felony against
persons
- Had not had an arrest for a
forcible felony within the past five
years
- Had not had an arrest for a felony
against persons while under current
supervision” (p17-18)
Member of the court team
Private attorney
Public defender
Probation officer
Judge,
Other justice system staff
(Stageberg et al., 2001, p. 22)
Treatment was given by a wide range
of providers in the region, and would
include urine testing with responses to
test results being tailored to the
individual
Participants also had regular reviews
at court, intensive probation
supervision, and were required to do
community service.
43.5% graduated within the two-
year study period (49% of women
and 38% of men)
White participants were more
likely to graduate than black
participants, which may be due to
differences in drug of choice and
associated treatment effectiveness.
Aged 21 to 25 or 36 to 40,
Married or divorced at intake
Having graduated from high
school
Weekly income of $300 or more at
programme termination
Having used drugs intravenously
or by inhalation rather than
smoking
No history of incarceration
C. Sirdifield et al. Forensic Science International: Mind and Law 1 (2020) 100031Abuse and Crime Prevention Act (SACPA) - a state-wide policy to divert
offenders with substance misuse problems away from the criminal justice
system and into treatment (Anglin et al., 2013; Chun et al., 2007; Evans
et al., 2014; Longshore et al., 2005). The policy has similarities to drug
courts as participants receive probation with drug treatment in lieu of
incarceration or probation without treatment. This includes those “on
probation or parole who commit nonviolent drug offenses or who violate
drug-related conditions of community supervision to elect
community-based treatment” (Anglin et al., 2013, p. 2). There are
various types of treatment available under this programme including
“drug education, regular and intensive outpatient drug-free treatment,
short- and long-term residential treatment, and pharmacotherapy”
(Longshore et al., 2005, p. 13) – often using methadone for those with
heroin dependence. However, SACPA differs from most drug courts in
that the programme is available to all offenders meeting conviction-based
eligibility criteria – i.e. areas cannot also introduce other eligibility
criteria such as addiction severity level (Evans et al., 2014). Additionally,
there are no funds within this programme for urine testing, and partici-
pants cannot be imprisoned for non-compliance – instead, they have
three opportunities to re-enter treatment after non-compliance.
Research findings suggest that SACPA has a positive impact on access
to and engagement with treatment (Anglin et al., 2013; Longshore et al.,
2005). The programme is also reported to have produced cost savings
(Anglin et al., 2013). However, Longshore et al. (2003) note that there
was variation in counties across California in which offence types were
eligible for SACPA, and on the proportion of probationers entering
SACPA on felony as opposed to misdemeanour convictions. This has
implications for programme costs.
The literature provides some insight into the characteristics of8
successful implementation of this approach, and the resources needed -
attendance rates for assessments could be increased by conducting the
assessments in or near the court, and allowing people more days to report
for assessment (Longshore et al., 2005, p. 53).
Variation in treatment completion is reported by: ethnicity – 37.5% of
Whites, 38.8% of Asian/Pacific Islanders, 29.4% of African Americans,
32.2% of Hispanics, and 29.8% of Native Americans completed treat-
ment; age – older clients were more likely to complete treatment; primary
drug of choice – completion rates were 28.3% for heroin users, and
35.2% for methamphetamine users; years of drug use – those with more
years of use had a higher completion rate; and probation versus parole –
the completion rate for probation was 35%, compared to 28.6% for those
on parole (Longshore et al., 2005).
In San Francisco County, probation and parole officers could refer
Proposition 36 cases to a centralised treatment access program where
they will be assessed within 30 days and directed to appropriate treat-
ment based on the outcomes of the assessment. Chun et al. (2007)
compared outcomes for 24 adults that were allocated to therapeutic
community treatment for persons receiving opioid replacement therapy
as a result of such assessments to those of 61 people that were on pro-
bation, but accessed treatment voluntarily. “More clients in the Propo-
sition 36 group (79%) were receiving methadone treatment at baseline
than those in the probation group (46%). Also, clients in the probation
group were more likely to have been incarcerated in the 30 days pre-
ceding the baseline interview (36% vs. 13%, respectively) (Chun et al.,
2007, p. 704). The severity of drug use decreased over the 12-month
follow up period for both groups, but there was “no improvement in
either group for measures of medical, psychiatric, and family/social
problems, suggesting that additional targeted interventions in these areas
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706).
Finally, Evans et al. (2014) compared outcomes from Proposition 36
with outcomes from drug courts in California. “Both Prop 36 and the drug
courts diverted drug offenders from jail and prison and into
community-based treatment settings, and both programs reduced drug
use” (Evans et al., 2014, p. 919). However, when criminal justice out-
comes are considered, Prop 36 was less effective at reducing longer-term
recidivism. The researchers conclude that further “research is needed to
determine if better long-term outcomes result when drug offenders are
better assessed and matched to the most appropriate drug diversion
program” (Evans et al., 2014, p. 921) based on treatment and supervision
needs and previous criminal justice system involvement and drug-use
histories.
4.2.4. Other factors influencing treatment entry, retention, and outcomes
When considering any individual intervention, it is important to
consider not only precisely what type of treatment or intervention is
being offered and what that consists of, but also precisely how the
treatment or intervention is delivered. How do factors like the setting,
duration, or the professional background of the individual(s) delivering
the intervention influence outcomes? Several studies included in the
review considered these types of questions.
Findings from the first of these studies, a small-scale feasibility study,
suggested that buprenorphine opioid substitution treatment in primary
care, as opposed to a specialist facility, may be effective in terms of
reducing illegal drug use, and potentially in terms of reducing HIV risk
behaviours (Brown et al., 2013).
Kelly et al. (2013) conducted a secondary analysis of data from a
randomised clinical trial comparing the following methods of treating
opioid dependence: a) ‘interim methadone’ (four months receiving
methadone followed by methadone counselling), b) ‘standard metha-
done’ (both methadone and counselling over 12 months), or c) ‘restored
methadone’ (methadone and counselling for 12 months, with the latter
being provided by a counsellor with a reduced caseload). Groups b and c
were combined in the analysis. Here, there were no significant in-
teractions between criminal justice status, treatment group, and
self-reported number of days using heroin or cocaine, number of opioid
or cocaine positive tests, days in treatment over 12 months, days of
hospitalisation or criminal justice outcomes such as days or
incarceration.
In two US states, Alemi et al. (2006) compared ‘seamless combina-
tions’ of probation and substance misuse treatment (i.e. where these
services are co-located and work together), with ‘traditional probation’,
where clients choose whether or not to access treatment outside of the
criminal justice system. In terms of health outcomes, those in the
‘seamless’ group had more days in treatment and more days in mental
health hospitals than the ‘traditional’ group, but had fewer days in
physical health hospitals. When considering both health and criminal
justice outcomes combined, the researchers concluded that seamless
probation is not more cost-effective than traditional probation.
Claus and Kindleberger. (2002) examined factors influencing treat-
ment entry and drop out for an opportunity sample of 260 individuals
with substance misuse problems that had been assessed at a central
intake unit that then matched them with an appropriate treatment pro-
vider. The study focused on those receiving outpatient treatment, and
those receiving residential treatment. Those receiving residential treat-
ment were more likely to attend and to stay in treatment rather than
dropping out. A shorter wait between the initial assessment and receipt of
treatment increased the likelihood of treatment attendance. However,
this relationship was not statistically significant when the researchers
controlled for the level of care and addiction severity. Those that were on
probation and those reporting a history of physical or sexual abuse were
more likely to drop out of treatment (Claus& Kindleberger, 2002, p. 28).9
4.2.5. Role of probation
Finally, it is important to consider the impact of community super-
vision itself on substance misuse. Hearnden. (2000) interviewed 278
offenders and 15 main grade Probation Officers in what was then Inner
London Probation Service in the UK, and explored the role of probation
and other interventions in reducing drug misuse. Self-report data on drug
misuse and offending in the four weeks prior to arrest were compared
with those for the four weeks prior to interview. This showed that there
was a significant fall in drug use including injecting and associated
expenditure whilst on probation, together with a reduction in crime.
However, this was not straightforward, for example, half of the sample
continued to use heroin. Offenders largely felt that the impact of pro-
bation had been positive in terms of assistance to reduce drug misuse,
with 90% reporting that their officer had offered them assistance, and
over half feeling that their officer had been a great deal of help. However,
20% said probation assistance had not made any difference – sometimes
due to their own lack of motivation, or their officer's attitude. Sixty
percent felt that the most important factors influencing levels of drug use
were personal factors rather than related to probation. Some offenders
felt that officers would benefit from more training, and some felt that
services could be improved, for example through provision of rehabili-
tation units and counselling, particularly from ex-users.
This view was reflected in data from interviews with staff, with some
feeling that they would benefit frommore training, and some stating that
most of their knowledge had been gained through working with other
agencies. Provision could be improved through more consistent provi-
sion of on-site services, and more flexibility around enforcing National
Standards with those with drug misuse problems.
5. Discussion
Clearly if we are to reduce substance misuse amongst people under
community supervision, commissioning should be informed by a detailed
understanding of needs, and of the most effective ways of addressing
them in different populations and settings.
The research identified in this review provides some background in-
formation on the prevalence and complexity of substance misuse
amongst people under community supervision, and factors that may in-
crease an individual's likelihood of misusing drugs and/or alcohol. In
addition, it evidences some of the benefits of effective interventions in
preventing deaths and reducing harm associated with substance misuse.
There is a high prevalence of substance misuse problems amongst people
on probation when compared to the general population (Brooker, Sirdi-
field, Blizard, Denney, & Pluck, 2012; Brooker, Syson-Nibbs, Barrett, &
Fox, 2009; Geelan, Griffin, Briscoe, & Haque, 2000; Mair & May 1997;
Martyn, 2012; Newbury-Birch, Harrison, Brown, & Kaner, 2009; Pari,
Plugge, Holland, Maxwell, & Webster, 2012). Indeed, many people on
probation will misuse more than one type of drug, or misuse a combi-
nation of both drugs and alcohol (Martyn, 2012; Murphy& Sweet, 2004).
However, the range of data available is limited, and in some cases,
quite dated. Commissioners and practitioners in the health and justice
field would benefit from research-informed and up-to-date information
about the prevalence of substance misuse, and the extent to which need is
being met by service provision. Patterns of drug use are subject to change
– as demonstrated by the recent rise in new psychoactive substances.
Treatment therefore needs to be flexible and adaptive. Ideally, rather
than being collected solely for research purposes, or for one-off needs
assessments, resources would be invested by government into staffing
and IT to enable such data to be collected and shared amongst agencies as
routine practice. In this way, commissioners would be able to base de-
cisions on an up-to-date needs profile.
Once the nature and complexity of needs is understood, we require
evidence on the most effective ways of addressing them. How can we best
provide services that reduce substance misuse, and associated offending
behaviour? Exactly what do we wish services to achieve – should we be
considering harm reduction as well as achieving abstinence when
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groups and settings are they best suited to? What resources do they
require, and are there any particular aspects of how an intervention is
delivered that will increase or decrease the likelihood of positive out-
comes being achieved?
In relation to these questions, we identified a diverse range of liter-
ature on ways of addressing substance misuse problems for those in
contact with probation or on parole. However, it is difficult to draw firm
conclusions from much of this literature due to its heterogeneity in terms
of the specific types of treatment and intervention being investigated,
and the methodological approaches being employed. We did not use
quality assessment to exclude studies from this review, andmany of those
included were small-scale and/or noted that further research is needed to
establish the generalisability of their findings (see for example Brodie
et al., 2009; Brown et al., 2013; Claus & Kindleberger, 2002; Cropsey
et al., 2011; Hollway et al., 2007; J. F. Kelly et al., 2005; Martin et al.,
2004; Martin et al., 2003). We grouped the studies into specific types of
treatment or intervention, but even within these categories, there was a
huge amount of variation. For example, whilst we identified a relatively
large amount of literature relating to specialised courts, and this provided
evidence to suggest that such courts may have positive impacts in terms
of engaging people in treatment and reducing substance misuse, there
was huge variation in terms of eligibility criteria, programme content,
programme structure, staffing, and graduation rates achieved. Thus
recommending any one model is problematic. Indeed a paper published
after this review was completed questions the public health benefit of
some models due to variation in whether or not particular
evidence-based forms of treatment are offered (Csete, 2020). Outcomes
in many studies were affected by participant and programme charac-
teristics and the context within which programmes were delivered.
Further research should build on this to offer further insight into how
provision can be tailored to give maximum benefit to different groups.
It is clear from this review, that conducting research in the ‘real world
setting’ of criminal justice, with populations that may be difficult to
engage is far from easy. However, if commissioners are to make evidence-
based decisions about how best to address substance misuse problems
amongst those under community supervision, it is vital that they have an
improved evidence base to draw upon. Alongside other areas of health-
care (Brooker, et al., 2020; Sirdifield, et al., 2020), it appears that
currently, substance misuse in probation and parole populations is a field
where very little meaningful research money is invested worldwide.
Given the size of the problem, this is worth underlining.
Internationally, substance misuse is a highly important issue, for
example in England andWales, in their latest health strategy (NPS, 2019)
the National Probation Service state:
‘An MoJ study of individuals starting Community Orders in 2009/10
showed that of those who received a formal assessment, 32% were iden-
tified as having a drug misuse need and 38% an alcohol problem.’
Many presentations of drug/alcohol problems are further com-
pounded by the complexity of the presentation. In our own prevalence
study of mental health problems in probation (Brooker, C., Sirdifield, C.,
Blizard, R., Denney, D. & Pluck, G, 2012) we found that just over 70% of
those with a mental health disorder also had a substance misuse problem
and, of course, high levels of the probation population also screen posi-
tive for a personality disorder (nearly 90% of all those with a mental
health disorder).
Despite this, drug and alcohol services in England have suffered big
budget reductions as part of the Government's austerity measures
(2012–2019). It has been reported that services have received budget
cuts between 30 and 50% over the last few years as previously ring-
fenced monies in Local Authorities have been seriously reduced (Drum-
mond, 2017).
At the same time as services have been reduced there has been an
alarming increase in the mortality associated with drug and alcohol use.10The Office of National Statistics (ONS) has recently confirmed the highest
ever annual increase in drug related deaths in England and Wales since
records began. There were 4359 deaths related to drug poisoning in
England andWales in 2018 in comparison with 3756 in 2017, an increase
of 16% year on year (Office for National Statistics, 2019). The ONS report
also highlighted the continuation of opiate-related deaths as the most
frequently reported and a doubling of cocaine related deaths.
The National Probation Strategy for Health and Social Care (NPS,
2019) stated that the:
NPS will work with local partners to improve referral pathways for any
individual who may benefit from substance misuse treatment and/or ser-
vices (National Probation Service, 2019: 13).
It is our belief that proper funding is needed to enable key gaps in the
literature to be addressed to ensure not only that clear pathways are in
place, but that the support that they lead to is research-informed and
produces positive outcomes for those accessing it.
Funding
This article presents independent research funded by the National
Institute for Health Research (NIHR) under its Research for Patient
Benefit (RfPB) Programme (Grant Reference Number PB-PG-0815-
20012). The views expressed are those of the author(s) and not neces-
sarily those of the NIHR or the Department of Health and Social Care.
Declaration of competing interest
The authors have no competing interests to declare.
Acknowledgements
ANONYMISED for her support with developing the search strategy.
References
Alemi, F., Taxman, F., Baghi, H., Vang, J., Thanner, M., & Doyon, V. (2006). Costs and
benefits of combining probation and substance abuse treatment. The Journal of Mental
Health Policy and Economics, 9(2), 57–70.
Anglin, M. D., Nosyk, B., Jaffe, A., Urada, D., & Evans, E. (2013). Offender diversion into
substance use disorder treatment: The economic impact of California's proposition
36. American Journal of Public Health, 103(6), 1096–1102. https://doi.org/10.2105/
AJPH.2012.301168
Ashby, J., Horrocks, C., & Kelly, N. (2010). Delivering the Alcohol Treatment
Requirement: Assessing the outcomes and impact of coercive treatment for alcohol
misuse. Probation Journal, 58(1), 52–67. https://doi.org/10.1177/
0264550510381325
Brewster, M. P. (2001). An evaluation of the Chester County (PA) drug court program.
Journal of Drug Issues, 31(1), 177–206. https://doi.org/10.1177/
002204260103100110
Brodie, J. D., Case, B. G., Figueroa, E., Dewey, S. L., Robinson, J. A., Wanderling, J. A.,
et al. (2009). Randomized, double-blind, placebo-controlled trial of vigabatrin for the
treatment of cocaine depdendence in Mexican parolees. American Journal of
Psychiatry, 166(11), 1269–1277. https://doi.org/10.1176/appi.ajp.2009.08121811
Brooker, C., & Ramsbotham, D. (2014). Probation and mental health: Who cares? British
Journal of General Practice, 64(621), 170–171. https://doi.org/10.3399/
bjgp14X677743
Brooker, C., Sirdifield, C., Blizard, R., Denney, D., & Pluck, G. (2012). Probation and
mental illness. Journal of Forensic Psychiatry and Psychology, 23(4), 522–537. https://
doi.org/10.1080/14789949.2012.704640
Brooker, C., Sirdifield, C., & Marples, R. (2020). Mental health and probation: A
systematic review of the literature. Forensic Science International: Mind and Law,
1(100003), 1–9. https://doi.org/10.1016/j.fsiml.2019.100003
Brooker, C., Sirdifield, C., Ramsbotham, D., & Denney, D. (2017). NHS commissioning in
probation in England - on a wing and a prayer. Health and Social Care in the
Community, 25(1), 137–144. https://doi.org/10.1111/hsc.12283
Brooker, C., Syson-Nibbs, L., Barrett, P., & Fox, C. (2009). Community managed offenders'
access to healthcare services: Report of a pilot study. Probation Journal, 56(1), 45–59.
https://doi.org/10.1177/0264550509102401
Brown, R., Gassman, M., Hetzel, S., & Berger, L. (2013). Community-based treatment for
opioid dependent offenders: A pilot study. American Journal on Addictions, 22,
500–502. https://doi.org/10.1111/j.1521-0391.2012.12049.x
Carter, J., Ryan, M., & Scott, S. (2000). Creating a DIN to tackle drug-related deaths in the
community. Journal of Clinical Forensic Medicine, 7, 130–138. https://doi.org/
10.1054/jcfm.2000.0428
C. Sirdifield et al. Forensic Science International: Mind and Law 1 (2020) 100031Chun, J., Guydish, J. R., Sorensen, J. L., Haug, N. A., Andrews, S., & Nelson, L. (2007).
Outcomes in a sample of opioid-dependent clients treated under California's
Proposition 36. Journal of Drug Issues, 37(3), 699–715. https://doi.org/10.1177/
002204260703700310
Claus, R. E., & Kindleberger, L. R. (2002). Engaging substance abusers after centralized
assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs,
34(1), 25–31. https://doi.org/10.1080/02791072.2002.10399933
Collins, B. J., Cuddy, K., & Martin, A. P. (2016). Assessing the effectiveness and cost-
effectiveness of drug intervention programmes: UK case study. Journal of Addictive
Diseases, 36(1), 5–13. https://doi.org/10.1080/10550887.2016.1182299
Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., …
Sititzer, M. L. (2011). Results of a pilot randomized controlled trial of buprenorphine
for opioid dependent women in the criminal justice system. Drug and Alcohol
Dependence, 119(3), 172–178. https://doi.org/10.1016/j.drugalcdep.2011.06.021
Csete, J. (2020). United States drug courts and opioid agonist therapy: Missing the target
of overdose reduction. Forensic Science International: Mind and Law, 1, 100024.
https://doi.org/10.1016/j.fsiml.2020.100024
Department of Health. (2013). Statutory guidance on Joint strategic needs assessments and
Joint health and wellbeing strategies. London: Department of Health.
Drummond, C. (2017). Colin Drummond: Cuts to addiction services are a false economy.
theBMJopinion. https://blogs.bmj.com/bmj/2017/05/25/colin-drummond-cuts-to
-addiction-services-in-england-are-a-false-economy/.
Eley, S., Gallop, k., McIvor, G., Morgan, K., & Yates, R. (2002). Drug treatment and testing
orders: Evaluation of the Scottish pilots. Edinburgh: Scottish Executive Central Research
Unit.
Evans, E., Li, L., Urada, D., & Anglin, M. D. (2014). Comparative effectiveness of
California's Proposition 36 and drug court programs before and after propensity score
matching. Crime & Delinquency, 60(6), 909–938. https://doi.org/10.1177/
0011128710382342
Fox, C., Albertson, K., Williams, K., & Ellison, M. (2011). Estimating the costs and benefits
of an alcohol treatment requirement. Drugs and Alcohol Today, 11(3), 147–155.
Geelan, S., Griffin, N., Briscoe, J., & Haque, M. S. (2000). A bail and probation hostel for
mentally disordered defendants. Journal of Forensic Psychiatry, 11(1), 93–104.
https://doi.org/10.1080/095851800362382
Gottfredson, D. C., & Exum, M. L. (2002). The baltimore city drug treatment court: One-
year results from a randomized study. Journal of Research in Crime and Delinquency,
39(3), 337–356. https://doi.org/10.1177/002242780203900304
Gray, R. M. (2002). The Brooklyn Program - innovative approaches to substance abuse
treatment. Federal Probation, 66(3), 9–16.
Gregoire, T. K., & Burke, A. C. (2004). The relationship of legal coercion to readiness to
change among adults with alcohol and other drug problems. Journal of Substance
Abuse Treatment, 26, 35–41. https://doi.org/10.1016/S0740-5472(03)00155-7
Gryczynski, J., Kinlock, T. W., kelly, S. M., O'Grady, K. E., Gordon, M. S., & Schwartz, R. P.
(2012). Opioid agonist maintenance for probationers: Patient-level predictors of
treatment retention, drug use, and crime. Substance Abuse, 33, 30–39. https://
doi.org/10.1080/08897077.2011.616816
Gyngell, K. (2011). The UK's treatment war on drugs: A lesson in unintended
consequences and perverse outcomes. The Journal of Global Drug Policy and Practice,
5(1).
Hall, M. T., Golder, S., Higgins, G. E., & Logan, T. K. (2016). Nonmedical prescription
opioid use among victimized women on probation and parole. Addictive Behaviors, 53,
113–119. https://doi.org/10.1016/j.addbeh.2015.10.008
Harrell, A., Cavanagh, S., & Roman, J. (2000). Evaluation of the D.C. Superior court drug
intervention programs. Washington D.C.: U.S. Department of Justice.
Hearnden, I. (2000). Problem drug use and probation in London: An evaluation. Drugs:
Education, Prevention and Policy, 7(4), 367–380. https://doi.org/10.1080/
dep.7.4.367.380
Hollway, T., Mawhinney, S., & Sheehy, N. (2007). Treating addiction, tackling crime: The
impact of probation-led residential treatment on offender substance misuse,
recidivism and attitudes towards the criminal justice system. Irish Probation Journal,
4(1), 108–124.
Jason, L. A., Olson, B. D., & Harvey, R. (2015). Evaluating alternative aftercare models for
ex-offenders. Journal of Drug Issues, 45(1), 53–68.
Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT):
A review of historical and clinical issues. Mount Sinai Journal of Medicine, 67(5&6),
347–363.
Kelly, J. F., Finney, J. W., & Moos, R. (2005). Substance use disorder patients who are
mandated to treatment: Characteristics, treatment process, and 1- and 5-year
outcomes. Journal of Substance Abuse Treatment, 28(3), 213–223. https://doi.org/
10.1016/j.jsat.2004.10.014
Kelly, S. M., O'Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011).
Predictors of methadone treatment retention from a multi-site study: A survival
analysis. Drug and Alcohol Dependence, 117, 170–175.
Kelly, S. M., O'Grady, K. E., Jaffe, J. H., Gandhi, D., & Schwartz, R. P. (2013).
Improvements in outcomes in methadone patients on probation/parole regardless of
counseling early in treatment. Journal of Addiction Medicine, 7(2), 133–138. https://
doi.org/10.1097/ADM.0b013e318284a0c1
Kleinpeter, C., Deschenes, E. P., Blanks, J., Lepage, C. R., & Knox, M. (2006). Providing
recovery services for offenders with co-occurring disorders. Journal of Dual Diagnosis,
3(1), 59–85. https://doi.org/10.1300/J374v03n01_06
Longshore, D., Urada, D., Evans, E., Hser, Y.-I., Prendergast, M., & Hawken, A. (2005).
Evaluation of the substance abuse and crime prevention Act. Los Angeles: University of
California Los Angeles.11Loue, S. (2003). The criminalization of the addictions. Toward a unified approach. The
Journal of Legal Medicine, 24, 281–330. https://doi.org/10.1080/
01947640390231948
Mackin, J., Carey, S. M., Finigan, M. W., Lucas, L. M., Strong, S. E., & Waller, M. S. (2008).
Harford County district court adult drug court outcome and cost evaluation.
Mair, G., & May, C. (1997). Offenders on probation, Home Office research study 167. London:
Home Office.
Marchand, G., Waller, M., & Carey, S. M. (2006). Kalamazoo county adult drug treatment
court outcome and cost evaluation. Final report. Portland: NPC Research.
Martin, B. K., Clapp, L., Alfers, J., & Beresford, T. P. (2004). Adherence to court-ordered
disulfiram at fifteen months: A naturalistic study. Journal of Substance Abuse
Treatment, 26, 233–236. https://doi.org/10.1016/S0740-5472(03)00208-3
Martin, B. K., Clapp, L., Bialkowski, D., Bridgeford, D., Amponsah, A., Lyons, L., et al.
(2003). Compliance to supervised disulfiram therapy: A comparison of voluntary and
court-ordered patients. American Journal on Addictions, 12, 137–143. https://doi.org/
10.1111/j.1521-0391.2003.tb00611.x
Martyn, M. (2012). Drug and alcohol misuse among adult offenders on probation
supervision: Findings from the drugs and alcohol survey 2011. Irish Probation Journal,
9, 75–93.
McSweeney, T., Stevens, A., Hunt, N., & Turnbull, P. J. (2007). Twisting arms or a helping
hand? Assessing the impact of 'coerced' and comparable 'voluntary' drug treatment
options. British Journal of Criminology, 47, 470–490. https://doi.org/10.1093/bjc/
azl087
Murphy, D., & Sweet, A. (2004). Substance misuse and offending: An innovative
partnership providing assessment and treatment. Irish Probation Journal, 1(1), 14–16.
National Probation Service. (2019). National probation service health and social care strategy
2019-2022. London: HM Prison and Probation Service.
Newbury Birch, D., Harrison, B., Brown, N., & Kaner, E. (2009). Sloshed and sentenced: A
prevalence study of alcohol use disorders among offenders in the north east of
England. International Journal of Prisoner Health, 5(4), 201–211. https://doi.org/
10.1080/17449200903343183
NHS Commissioning Board. (2012). Commissioning fact sheet for clinical commissioning
groups. London https://www.england.nhs.uk/wp-content/uploads/2012/07/fs-ccg-r
espon.pdf.
NHS Commissioning Board. (2013). Securing excellence in commissioning in offender health.
London http://www.england.nhs.uk/wp-content/uploads/2013/03/offender-commi
ssioning.pdf.
Nicosia, N., Kilmer, B., & Heaton, P. (2016). Can a criminal justice alcohol abstention
programme with swift, certain, and modest sanctions (24/7 sobriety) reduce
population mortality? A retrospective observational study. Lancet Psychiatry, 3,
226–232. https://doi.org/10.1016/S2215-0366(15)00416-2
Office for National Statistics. (2019). Deaths related to drug poisoning in England and Wales:
2018 registrations. London: Office for National Statistics.
Osborne, A. (2013). Future delivery of the drug interventions programme: Do the benefits
justify the costs? Journal of Forensic and Legal Medicine, 20, 816–820. https://doi.org/
10.1016/j.jflm.2013.06.022
Pari, A. A. A., Plugge, E., Holland, S., Maxwell, J., & Webster, P. (2012). Health and
wellbeing of offenders on probation in England: An exploratory study. The Lancet,
380(S21). https://doi.org/10.1016/S0140-6736(13)60377-3
Powell, C., Bankart, J., Christie, M., Bamber, D., & Arrindell, T. (2009). Drug testing in the
criminal justice system: Solutions to a costly commodity. Journal of Substance Use,
14(6), 393–407. https://doi.org/10.3109/14659890902963868
Revolving Doors Agency. (2017). Rebalancing Act. A resource for Directors of Public Health,
Police and Crime Commissioners, the police service and other health and justice
commissioners, service providers and users. London: Revolving Doors Agency.
Sia, T. L., Dansereau, D. F., & Czuchry, M. L. (2000). Treatment readiness training and
probationers' evaluation of substance abuse treatment in a criminal justice setting.
Journal of Substance Abuse Treatment, 19, 459–467. https://doi.org/10.1016/s0740-
5472(00)00139-2
Sirdifield, C., Brooker, C., & Marples, R. (2020). Suicide and probation: A systematic
review of the literature. Forensic Science International: Mind and Law, 1. https://
doi.org/10.1016/j.fsiml.2020.100012, 100012.
Sirdifield, C., Marples, R., Brooker, C., Denney, D., Siriwardena, A. N., Maxwell-
Harrison, D., et al. (2019). Probation healthcare commissioning toolkit: A resource for
commissioners and practitioners in health and criminal justice. Lincoln: University of
Lincoln. https://probhct.blogs.lincoln.ac.uk/. (Accessed 8 September 2020).
Small, D. (2007). Fools rush in where angels fear to tread. Playing God with Vancouver's
supervised injection facility in the political borderland. International Journal of Drug
Policy, 18, 18–26. https://doi.org/10.1016/j.drugpo.2006.12.013
Stageberg, P., Wilson, B., & Moore, R. G. (2001). Final report on the Polk County adult drug
court. Iowa: Iowa Department of Human Rights Division of Criminal and Juvenile
Justice Planning Statistical Analysis Center.
Turnbull, P. J., & Webster, R. (2007). Supervising crack-using offenders on drug treatment
and testing orders. London: National Treatment Agency for Substance Misuse.
Walters, S. T., Ondersma, S. J., Ingersoll, K. S., Rodriguez, M., Lerch, J., Rossheim, M. E.,
& Taxman, F. S. (2014). MAPIT: Development of a web-based intervention targeting
substance abuse treatment in the criminal justice system. Journal of Substance Abuse
Treatment, 46, 60–65.
Winter, R. J., Young, J. T., Stoove, M., Agius, P. A., Hellard, M. E., & Kinner, S. A. (2016).
Resumption of injecting drug use following release from prison in Australia. Drug and
Alcohol Dependence, 168, 104–111. https://doi.org/10.1016/
j.drugalcdep.2016.08.640
